(Bloomberg) -- Pfizer Inc. sued Metsera Inc. and rival drugmaker Novo Nordisk A/S to block the Danish company’s rival bid for the obesity startup. In a statement Friday, Pfizer said the Novo offer can ...
In the latest quarter, 7 analysts provided ratings for Pfizer (NYSE:PFE), showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results